¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"macrophage aggregating factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
coagulation factor inhibitor
ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
colony-stimulating factor
Áý¶ôÀÚ±ØÀÎÀÚ
common factor
°øÅëÀÎÀÚ
competence factor
1. ¸é¿ª°¡´ÉÀÎÀÚ 2. ¹ÝÀÀ°¡´ÉÀÎÀÚ
competence inducing factor
¸é¿ª°¡´ÉÀ¯¹ßÀÎÀÚ
complementary factor
º¸ÃæÀÎÀÚ
conglutinogen activating factor
±³Âø¿øÈ°¼ºÀÎÀÚ
conversion factor
º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
carcinogenic factor
¹ß¾ÏÀÎÀÚ
corticotropin-releasing factor
ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
chemotactic factor
ÈÇнò¸²ÀÎÀÚ
drug resistance factor
¾àÁ¦ÀúÇ×ÀÎÀÚ
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢º´À¯¹ßÀÎÀÚ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
behavioral risk factor
ÇൿÀ§Çè¿äÀÎ
carcinogenic factor
¹ß¾ÏÀÎÀÚ
chemotactic factor
ÈÇÐÁÖ¼ºÀÎÀÚ, ÈÇнò¸²ÀÎÀÚ
coagulation factor
ÀÀ°íÀÎÀÚ
coagulation factor inhibitor
ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
colony-stimulating factor
Áý¶ôÀÚ±ØÀÎÀÚ
common factor
°øÅëÀÎÀÚ
competence factor
Àû°ÝÀÎÀÚ
competence inducing factor
Àû°ÝÀ¯¹ßÀÎÀÚ
complementary factor
º¸ÃæÀÎÀÚ, º¸Ã¼ÀÎÀÚ
conglutinogen activating factor
±³Âø¿øÈ°¼ºÀÎÀÚ
conversion factor
º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
corticotropin releasing factor
ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó¹æÃâÀÎÀÚ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
Factor XI
XI ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor XII
XII ÀÀ°íÀÎÀÚ(ëêͳì×í)
Fibrin-stabilizing factor
¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ(¡äÌïÒì×í)
Fibroblast growth factor
¼¶À¯¸ð¼¼Æ÷(àéë«Ù½á¬øà)¼ºÀå¿äÀÎ(à÷íþé©ì×)
G-CSF (Granulocyte colony-stimulating factor)
°ú¸³¼¼Æ÷±ºÃËÁøÀÎÀÚ(Î¨Ø£á¬øàÏØõµòäì×í)
GH releasing factor
¼ºÀå(à÷íþ)È£¸£¸ó À¯¸®ÀÎÀÚ(ë´×îì×í).
GH releasing factor
¼ºÀåÈ£¸£¸óÀ¯¸®ÀÎÀÚ.
Growth factor
¼ºÀåÀÎÀÚ(à÷íþì×í)
Hageman factor
ÇϰԸ¸ÀÎÀÚ
Hydrostatic factor
Á¤¼öÀÎÀÚ(ð¡â©ì×í)
IGF-I(insulin-like growth factor-I)
Àν¶¸° À¯»ç ¼ºÀåÀÎÀÚ-1
Luteinization -inhibiting factor
ȲüȾïÁ¦¿äÀÎ(üÜô÷ûùåäð¤é©ì×)
NGF=>nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
PAF =platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ.
PAF= platelet activating factor
Ç÷¼ÒÆÇ Ȱ¼ºÀÎÀÚ.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
macrophage migration inhibition test
´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁö½ÃÇè.
macrophage migration test
´ë½Ä¼¼Æ÷ À¯ÁÖ½ÃÇè(¡ë´ñËãËúÐ).
macrophage system
Å«Æ÷½Ä¼¼Æ÷°è, ´ë½Ä¼¼Æ÷°è(Åë)(¡Í§÷Ö).
macrophage system
´ë½Ä¼¼Æ÷°è(¡Í§).
macrophage,activation of
Ȱ¼ºÈ(üÀàõûù)
macrophage,foamy
Æ÷¸»¼º(øÜØÈàõ)
peritoneal macrophage
º¹¸· ´ë½Ä¼¼Æ÷
peritoneal macrophage
º¹°´ë½Ä¼¼Æ÷, º¹°°Å½Ä¼¼Æ÷
resident macrophage
»óÁÖ´ë½Ä¼¼Æ÷, »óÁְŽļ¼Æ÷
wandering macrophage
ÀÚÀ¯Å«Æ÷½Ä¼¼Æ÷
absorbed dose conversion factor
Èí¼ö¼±·®º¯È¯°è¼ö
age factor
¿¬·ÉÀÎÀÚ.
air kerma calibration factor
°ø±âÄ¿¸¶ÃøÁ¤°è¼ö, -´«±Ý¸ÂÃã°è¼ö
alveolar dilution factor
ÆóÆ÷Èñ¼®ÀÎÀÚ(¡ýüà·ì×í).
amplification factor
ÁõÆøÀÎÀÚ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½